|Articles|April 26, 2023
Supplements and Featured Publications
- Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion
Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion
Advertisement
This publication was sponsored by Acadia Pharmaceuticals Inc.
This clinical brief provides insights from a panel of stakeholders about Parkinson disease (PD) and the prevalence and care of PD psychosis (PDP). The experts also offer key information about PDP from the payer and clinical perspectives.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
2
Executive Order on Homelessness Includes Several Policy Shifts: Katherine Koh, MD, MSc
3
Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds
4
Policy Changes, Price Negotiations Challenge Oncology Innovation: Ryan Haumschild, PharmD, MS, MBA, CPEL
5